Noeul secures a $975,000 deal with Ghana! What happened?
On August 25, 2025, Noeul signed a contract with Resolved Engineering Limited to supply and grant exclusive distribution rights for the miLab platform, malaria diagnostic cartridges (MAL), blood cell morphology cartridges (BCM), SafeFix (consumables), and miLab software within Ghana. The contract is valued at USD 975,000 and will last for two years.
Why is the Ghana expansion significant?
This contract is more than just a sales agreement; it holds significant implications for securing Noeul’s future growth engine.
- New Market Entry: Africa, a region with lacking medical infrastructure, presents an opportunity for Noeul’s miLab™ platform to significantly contribute to improving local healthcare accessibility. This will be a new growth driver for Noeul.
- Global Reference Acquisition: Successful entry into Ghana will serve as a vital reference for future expansion into other countries.
- Expected Revenue Increase: This contract is expected to positively impact Noeul’s revenue goals for 2025 and 2026.
What should investors do?
Along with the positives, investors should also be aware of some risk factors.
- Continuing Deficit: Noeul is still operating at a loss. It may be difficult for this contract to lead to a turnaround in the short term.
- Exchange Rate and Macroeconomic Risks: Investors should consider external factors such as exchange rate fluctuations due to the USD contract and changes in Ghana’s political and economic situation.
Therefore, investment decisions should be made after comprehensively considering the company’s efforts to improve profitability, the performance of its global market expansion strategy, and changes in the external environment.
Frequently Asked Questions
What is the miLab™ platform?
miLab™ is an AI-powered, on-device healthcare solution platform developed by Noeul. It facilitates quick and accurate on-site diagnoses, including blood tests.
How will this contract affect Noeul’s financial status?
While it will contribute to increased sales, it is unlikely to lead to profitability in the short term. It is positive for securing long-term growth momentum.
What precautions should investors take?
Investors should consider Noeul’s continuing deficit, exchange rate volatility, and the political and economic situation in Ghana. Continuous monitoring of the company’s efforts to improve profitability and changes in the market situation is crucial.